National collaborative study for establishing the working reference material of the vaccine against measles/mumps and rubella: evolution to the self-sufficiency in the national production of triple viral vaccine
Keywords:
reference material, biological potency, MMR vaccine
Abstract
The pharmacopoeia monograph for the measles/mumps and rubella (MMR) triple vaccine demands to perform the validation of the potency assay by using the suitable reference material (MR). Aiming at establishing the first work MR (MRT) for the MMR triple vaccine, a national collaborative study was performed with the participation of the two unique national institutions working on the vaccine potency evaluation test, the Imunobiological Technology Institute (Bio-Manguinhos, national manufacturer) and the National Institute for Quality Control in Health. The candidate product (cMRTBio) prepared by the manufacturer was evaluated by the participant laboratories by employing the respective in-house methodologies for determining the potency. The cMRTBio was considered suitable as in-house MR, according to the specifications based on the normative compendia, being the intra-assay (< 5 %), inter-assay(< 10 %) and between laboratories variations (< 10 %) below the acceptable limits, and the estimate potency (log10 CCID50/DH) in 3.72 for measles, 4.80 for mumps and 3.70 for rubella. This study reflects the commitment of the unique national MMR vaccine producer to the public health, describing the expansion of technology, the compliance with international guidelines and the careful quality control, leading to the national self-sufficiency in the vaccine production.
Published
2016-05-05
How to Cite
Almeida, D. da S., Dick, P. C., Silva, C. J. da, Medeiros, I. P. de, Oliveira, C. C. P. de, Hokama, D. A., Santos, J. E. dos, Alves, P. dos S., Werneck, L. M. C., Seródio, L. R., Friedrich, K., & Mattos, K. A. de. (2016). National collaborative study for establishing the working reference material of the vaccine against measles/mumps and rubella: evolution to the self-sufficiency in the national production of triple viral vaccine. Revista Do Instituto Adolfo Lutz, 74(3), 178-189. Retrieved from https://periodicoshomolog.saude.sp.gov.br/index.php/RIAL/article/view/33471
Issue
Section
ORIGINAL ARTICLE